Macrophage-specific IGF-1 overexpression decreases plaque MMP8 and. by Patricia Snarski (22305205)

Subjects:

Results obtained following a decrease in laser intensity by rotation of the Collison nebulizer. by Elliott Donghyun Kim (19469973)

“…<p>Results obtained following a decrease in laser intensity by rotation of the Collison nebulizer.…”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

The decreasing rates of V_p with temperature. by Nazlı Tunar Özcan (14833635)

Subjects:

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

Table1_RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in a... by Uwe Grether (1594096)

The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

“…Conclusions</p> <p>A transition from an increase to a decrease in AUC C-peptide approximately 1.5 years pre-diagnosis was validated in two independent cohorts. …”

Yearly crude rates normalized by their 1999 value. by Tony Wong (779773)

“…<p>Values below 1 indicate crude rate decreases relative to their 1999 value, those above 1 indicate increases. …”

Male-to-female ratios of yearly crude rates. by Tony Wong (779773)

“…<p>Although all ratios are consistently above unity, they are steadily decreasing across all age and race groups, particularly among younger cohorts. …”

The all-ages number of incidences urticaria by year. by Wenxi Xiao (22145724)

Subjects:

SEM morphology and EDS surface-scanning energy spectra of 17-4PH-xTiC coated abrasion marks: (a) 10%TiC; (b) 20%TiC; (c) 30%TiC; (d) 40%TiC. by Dian Yu Luo (22656111)

Marking example. by Qingjun Yu (1649473)

Persistence of β-cell responsiveness for over two years in autoantibody-positive children with marked metabolic impairment at screening by Emily K. Sims (5278130)

“…</p> <p><strong>Results:</strong> Longitudinal analyses revealed annualized AUC C-peptide increases in non-progressors vs. decreases in progressors (p≤0.026 for DPT-1 and TNPTP). …”

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

WSSV infection damages the mechanical performance of the shrimp cuticle and decreases the chitin content. by Xin-Xin Wang (135520)

“…The recombinant chitin binding domain (CBD) from <i>Bacillus circulans</i> WL-12 Chitinase A1 was used to mark chitin, and FITC-labeled antibodies were used to visualize the bound CBD; scale bar, 20 μm. …”

The proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases in <i>APC</i>-mutant colon tissues from FAP patients. by Tao Zhang (43681)

“…Results show that, in normal crypts, the distribution and proportion of cells staining for ALDH1 and CGA are very similar. In contrast, in <i>APC</i>-mutant tissues from FAP patients, the proportion of ALDH+ cells progressively increases while CGA+ cells markedly decreases. …”

Generalizable improvement of QOL measures on day 7 vs. infusion day. by Jordan K. Abbott (8934239)

Subjects:

Predicted change in wine sold (% (95% CI)) after removing the largest serving sizes by the glass, derived from the generalised additive linear mixed model. by Eleni Mantzari (6991172)

Subjects:

Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx by Livia De Picker (8319105)

“…Increased CRP, CCL2, and IL1RA, and decreased KA and KA/Kyn are trait markers of psychotic illness.…”

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…(B) Oxygen consumption rates were measured using a Seahorse Bioscience XF96 extracellular flux analyzer in A375 melanoma cells treated with or without 1.0 μM 12-TPP (N = 4). At the 25 min mark, 1.0 μM 12-TPP was added to treatment A375 cells followed by the sequential addition of 2.5 μM oligomycin at the 60 min mark, 0.3 μM oligomycin at the 90 min mark, and 5.0 μM rotenone/antimycin A at the 120 min mark. …”